Historical Stock Chart
2 Months : From Nov 2019 to Jan 2020
By Chris Wack
Synthorx Inc. (THOR) shares almost tripled to $68.05 in early trading after Sanofi SA (SAN.FR) said it was buying the clinical-stage biotechnology for $68 a share in cash.
The deal has an equity value of about $2.5 billion, and is expected to close in the first quarter of next year.
Write to Chris Wack at firstname.lastname@example.org
(END) Dow Jones Newswires
December 09, 2019 10:13 ET (15:13 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.